Past Events

The 2016 Alzheimer’s Disease Congress: 7th – 9th June 2016

Off

London UK 7th- 9th June 2016


 This three day international academic congress will discuss current research and treatments being developed for Alzheimer’s Disease.


Agend       Abstract book


Topics for discussion include prediction and prevention strategies, vaccine development, drug discovery and care.

With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding Alzheimer’s Disease.


Deadlines

The abstract submissions deadline for oral presentation is 10th March 2016

The early registration deadline is 20th April 2016

The Poster submission deadline in 26th May 2016


The 2016 Alzheimer’s Disease Congress has an open abstract session:  Abstracts for oral or poster presentation can be submitted on any subject related to Alzheimer’s


This  event  is  now over

There  will be a meeting report in due course

For the follow up meeting please see www.lifescienceevents.com/alz2017


Talks include

Talk TitleSpeakerAffiliationCountry
Calcium, Memory and Alzheimer's diseaseSir Michael BerridgeThe Babraham InstituteUnited Kingdom
Drugs used in multiple pathologies, with stresses common to Alzheimers disease, offer candidate drugs and vaccine potential for Alzheimers diseaseProfessor Joan Smith SonnebornUniversity of WyomingUnited States
Targeting Nucleophilic Attack During Early Beta-Amyloid Peptide OligomerizationAdrien W. SchmidEcole Polytechnique Fédérale de Lausanne (EPFL)Switzerland
Neurophysiological vulnerability to aging associated with the Alzheimer’s risk variant in CLU geneDr Natalya PonomarevaResearch Center of NeurologyRussian Federation
The role of heparan sulfates in the amyloid pathology of Alzheimer diseaseCharlotte JendresenUniversity of Oslo and Oslo University HospitalNorway
Cholesterol's contribution to autophagy deficits in Alzheimer’s diseaseDr Anna ColellSpanish National Research Council (CSIC)Spain
Granulovacuolar degeneration, a neurodegenerative change that accompanies tau pathologyDr Christoph KöhlerUniversity of CologneGermany
Looking for the markers of asymptomatic stage of Alzheimer's disease in the retinaDr Slavica KranticUPMCFrance
Sigma-1 receptor ligand Fluvoxamine modulates production of amyloid beta peptides in vitro and is protective in J20 Alzheimer disease miceAssociate Professor John BJ KwokNeuroscience Research AustraliaAustralia
Probing dementia-associated disruption of neural circuits using neurophysiology and imaging in murine modelsProfessor Andrew RandallUniversity of Exeter Medical SchoolUnited Kingdom
Link between the modifiable risk factors of Alzheimer's disease and neuroinflammationDr Andis KlegerisUniversity of British Columbia Okanagan CampusCanada
Paradigm Shift: Semantic memory decline as a biomarker of preclinical Alzheimer’s diseaseProfessor Annalena VenneriUniversity of SheffieldUnited Kingdom
The regulation of metastable proteins in neurodegenerative diseasesRishika KundraUniversity of CambridgeUnited Kingdom
c-Abl signaling in Alzheimer's disease and other Neurodegenerative diseases: Projections for drugs searchingDr Alejandra Alvarez R, Pontificia Universidad Catolica de ChileChile
EEG biomarkers and profiling of AD mouse linesProfessor Bettina PlattUniversity of AberdeenUnited Kingdom
Potential therapeutic strategies of Cerebrolysin in Alzheimer's DiseaseDr Hari Shanker SharmUppsala UniversitySweden
Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: systematic review and meta-analysisDr Vasiliki OrgetaUniversity College LondonUnited Kingdom
Fighting Alzheimers Disease Professor Michal SchwartzThe Weizmann Institute of ScienceIsrael
Smell identification function in Alzheimer's diseaseDr Latha VelayudhanUniversity of LeicesterUnited Kingdom
Multiple roles of cholinergic neurons in the modulation of amyloid productionDr Jane RylettSchulich Medicine & DentistryCanada
Alpha2 adrenergic receptor as a novel target for Alzheimer's diseaseDr. Qin WangUniversity of Alabama at BirminghamUnited States
Associations of sorLA/SORL1 with Alzheimers diseaseDr. Olav Michael AnderseAarhus UniversityDenmark
Chaperoning Tau aggregationDr. Stefan RüdigerUtrecht UniversityNetherlands
The role of proliferating astrocytes in Alzheimer's diseaseDr Magdalena SastreImperial College LondonUnited Kingdom
Imaging-related biomarkers of cognitive decline in healthy controls.Dr. Panteleimon GiannakopoulosUniversity Hospitals of GenevaSwitzerland
Inflammation in Dementia with Lewy bodies and Alzheimer's Disease Dr Jay AminUniversity of SouthamptonUnited Kingdom
Dystrophic neurites are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation: the potential role of Aβ oligomersProfessor Robert Vassar, Northwestern University Interdepartmental NeuroscienceUnited States
What makes an amyloidogenic protein toxic? Dissecting the sequence - self-assembly -toxicity relationship for amyloid peptidesProfessor Louise SerpellUniversity of SussexUnited Kingdom
Loss of neuroprotective lipids and myelin as a key sensitizing factor in Alzheimer’s pathogenesis.Dr Anthony Simon DonUniversity of New South WalesAustralia
Alzheimer's Disease: a clinical viewpointDr Amit AroraUniversity Hospital of North StaffordshireUnited Kingdom
The role of Pb in AD pathogenesisDr. Yansheng DuIndiana University School of MedicineUnited States
Computational studies on the toxicity mechanisms of amyloid beta peptides aggregation in relation to Alzheimer's diseaseProfessor Chew Lock YueNanyang Technological UniversitySingapore
Type 2 diabetes mellitus accelerate tau pathology in nonhuman primateDr. Zhiming ZhangUniversity of Kentucky College of MedicineUnited States
Is GluN2B-NMDA receptor a good target in treating Alzheimer's disease?Professor Qiang ZhouPeking University Shenzhen Graduate SchoolChina
The drug therapy to increase stem cells for treatment of Alzheimer/s diseaseDr. Kiminobu SugayaUniversity of Central FloridaUnited States
The involvement of type-1 interferon signalling and resultant neuroinflammation Alzheimer's DiseaseDr. Peter CrackThe University of MelbourneAustralia
Characterizing Prodromal Alzheimer's Disease Using Multimodality ImagingDr. Val LoweMayo Clinic RochesterUnited States
PET imaging biomarkers in Alzheimer's DiseaseProfessor Karl HerholzUniversity of ManchesterUnited Kingdom
Where did we go wrong in the study of APP processingDr. Ming Chen,University of South FloridaUnited States
Good things in small packages: The molecular chaperone action of the small heat shock chaperone proteinsProfessor Heath EcroydUniversity of WollongongAustralia
Proteostasis Collapse and Protein Aggregation in Neurodegenerative DiseasesDr. Justin YerburyUniversity of WollongongAustralia
Predicting Progression to Mild Cognitive Impairment in Cognitively Unimpaired Individuals Using Neuroimaging BiomarkersDr. Cynthia M. StonningtonMayo Clinic College of MedicineUnited States
Biomedical nanotechnology and Alzheimer's. Can the disease be reversed?Professor Christopher WhiteleyNational Taiwan University of Science and TechnologyTaiwan


Advisory Board Members

NameAffiliationCountry
Professor Jordan L Holtzman University of MinnesotaUnited States
Kaye ErvinUniversity of MelbourneAustralia
Dr Frank O. BastianLSU Agricultural CenterUnited States
Professor Sophia G. AntimisiarisUniversity of PatrasGreece
Professor Jane MortSouth Dakota State UniversityUnited States
Professor Urszula WojdaNencki Institute of Experimental BiologyPoland
Assistant Professor Myria PetrouUniversity of MichiganUnited States
Dr Mourad TayebiSurrey UniversityUnited Kingdom
Dr Philip LiuMass General Hospital and Harvard Medical SchoolUnited States
Professor Mark R WilsonUniversity of WollongongAustralia
Professor Qiang ZhouPeking University Shenzhen Graduate SchoolChina


CPD Credits


Related Past Event Agendas

thealzheimersdiseasecongress-agendaAlzheimers AgendaAgeing 2016 Agenda



 

Contact

Email:  enquiries [@] euroscicon.com

Phone: (+44) 020 7183 82 31

Registration Fee

Registration includes entry to all the event, lunch and all refreshments, networking opportunities and access to exhibitions.

FEE  FOR  THREE  DAYS

 

REGISTRATION FEE

 LATE REGISTRATION FEE

Standard

£534 (£445 + VAT)

£654 (£545 + VAT)

Academic

£354 (£295 + VAT)

£474 (£395 + VAT)

Student

£234  (£195 + VAT)

£354 (£295 + VAT)

If you do not want to attend the full three days you can also book single days at the following price

 

REGISTRATION FEE

 LATE REGISTRATION FEE

Standard

£234  (£195 + VAT)

£330  (£275 + VAT)

Academic

£150  (£125 + VAT)

£234  (£195 + VAT)

Student

£114  (£95 + VAT)

£174   (£145 + VAT)

Please note: As our services are held in the UK we are obliged to charge VAT even if you are coming from outside the UK

Discounted Group Bookings

If 3 or more people register together, then you will receive a discount of £20.00 off for each person in the group

These discounts are applied automatically on registration

Bursary applications

Euroscicon will consider all applications for bursaries to cover registration, food and refreshments on the day of an event, however these are limited.  We cannot, at this time award money for travel or accommodation.  To download an application form see www.euroscicon.com/Bursary.docx

Venue, Accommodation and Travel Details

This event will be held at Cineworld: The O2 Peninsula Square London SE10 0DX United Kingdom

www.TheO2.co.uk

Once inside the O2 building please make your way to Cineworld.  A map of the O2 can be found by clicking here

For more detailed travel information click here

For accommodation suggestions click here

Map

Abstract and Poster Presentations

All abstracts accepted for oral presentation are also automatically accepted for poster presentation

INSTRUCTIONS

Payment Instructions

Payment must be received prior to the meeting

Credit card
You can pay during your online registration using your credit card. Using this mode of payment you can guarantee that your fee has reached us prior to the conference and you will be listed as registered

Paypal
You can either use your Paypal account or click on the no account link to pay directly by credit or debit card

The information taken will be by secure server.

We do not store credit card details nor do we share customer details with any 3rd parties

If you wish to pay by cheque, purchase order or bank transfer, please contact sales [@] euroscicon.com

Cancellation Policy

Please note that we must receive payment in full before the meeting.

Delegates cancelling their registration at any point up to 2 months before the event will receive a full refund minus a £20.00 admin fee.

Delegates cancelling their registration at any point between 2 months and two weeks before the meeting will receive a 50% refund.

Delegates cancelling their registration two weeks before a meeting WILL NOT receive a refund.

Substitution of delegates can be made at any time through the registration system.

If you have not paid for a meeting that you have registered for and do not come (and do not provide 2 weeks notice of cancellation), you will be charged the full price of the meeting.

This will be a paperless meeting

Untitled Document
Please print out the agenda before you come or download the pdf onto your computer or smartphone.  
Pdfs of our agendas and abstract books can be found at www.lifescienceevents.com/events 

Latest Euroscicon Tweets

  • Astronauts prepare for Mars mission at the bottom of the sea: An international crew of astronauts dove to the... https://t.co/VphAVXKqgi
    about 2 hours ago